Literature DB >> 16287925

Comparison of the Health Assessment Questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis.

T Uhlig1, E A Haavardsholm, T K Kvien.   

Abstract

OBJECTIVES: Physical disability in patients with rheumatoid arthritis (RA) is often assessed by questionnaires. We compared the Health Assessment Questionnaire (HAQ) with the modified HAQ (MHAQ) in a cohort of RA patients across various levels of disability, and examined correlations with other measures of physical function.
METHODS: Patients with RA (n = 182) completed self-report questionnaires assessing functional capacity. Instruments included the MHAQ and HAQ completed separately, as well as SF-36 and the Arthritis Impact Measurement Scales (AIMS). Scores from unadjusted and adjusted HAQ were compared with MHAQ at various disability levels.
RESULTS: A clear ceiling effect with aggregation of normal scores for physical function was observed for MHAQ (23%) and HAQ (12%), but not for SF-36 (4%) or AIMS (5%). The correlations between adjusted/unadjusted HAQ and MHAQ scores were 0.85/0.88. A discrepancy in HAQ and MHAQ scores was observed in patients with high levels of disability, especially when MHAQ was compared with the adjusted final HAQ score. Adjustment of HAQ by aids or help increased the final score by an average of 0.15, and both adjusted and unadjusted HAQ scores were numerically clearly higher (mean 0.45 and 0.30, respectively) than the MHAQ score.
CONCLUSION: The present findings indicate that MHAQ and HAQ may be applicable as measures of physical capacity in RA patients, but clinicians and researchers should select the appropriate instrument for the setting, and be aware of differences in scores, especially at different disability levels.

Entities:  

Mesh:

Year:  2005        PMID: 16287925     DOI: 10.1093/rheumatology/kei181

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  19 in total

1.  Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation.

Authors:  Karen L Syrjala; Jean C Yi; Samantha B Artherholt; Allison C Stover; Janet R Abrams
Journal:  J Cancer Surviv       Date:  2010-05-08       Impact factor: 4.442

2.  2019 American College of Rheumatology Recommended Patient-Reported Functional Status Assessment Measures in Rheumatoid Arthritis.

Authors:  Claire E H Barber; JoAnn Zell; Jinoos Yazdany; Aileen M Davis; Laura Cappelli; Linda Ehrlich-Jones; Donna Everix; J Carter Thorne; Victoria Bohm; Lisa Suter; Alex Limanni; Kaleb Michaud
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-11       Impact factor: 4.794

3.  Evaluation of the stages of completion and scoring of the Patient Generated Index (PGI) in patients with rheumatic diseases.

Authors:  Andrew M Garratt
Journal:  Qual Life Res       Date:  2015-06-03       Impact factor: 4.147

4.  Assessment of hand functions in rheumatoid arthritis using SF-SACRAH (short form score for the assessment and quantification of chronic rheumatoid affections of the hands) and its correlation to disease activity.

Authors:  Harpreet Singh; Suresh Kumar; Paulomi Talapatra; Vikas Gupta; Sucharita Ray; Harish Kumar
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

5.  Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.

Authors:  E Aurrecoechea; J Llorca Díaz; M L Diez Lizuain; G McGwin; J Calvo-Alen
Journal:  Rheumatol Int       Date:  2016-12-16       Impact factor: 2.631

6.  Sociodemographic factors associated with functional disability in outpatients with rheumatoid arthritis in Southwest China.

Authors:  Shangping Zhao; Yanling Chen; Hong Chen
Journal:  Clin Rheumatol       Date:  2015-02-18       Impact factor: 2.980

7.  Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients.

Authors:  Nick Kontodimopoulos; Panagiotis Bozios; John Yfantopoulos; Dimitris Niakas
Journal:  Eur J Health Econ       Date:  2012-01-18

8.  Successful treatment using tacrolimus plus corticosteroid in a patient with RA associated with MDS.

Authors:  Yuji Nozaki; Yasuaki Nagare; Koji Kinoshita; Fumiaki Urase; Masanori Funauchi
Journal:  Rheumatol Int       Date:  2007-08-29       Impact factor: 2.631

Review 9.  Newer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity.

Authors:  Vibeke Strand; Jasvinder A Singh
Journal:  Drugs       Date:  2010       Impact factor: 9.546

Review 10.  Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis.

Authors:  Patricia Guyot; Peter Taylor; Robin Christensen; Louisa Pericleous; Coralie Poncet; Maximilian Lebmeier; Pieter Drost; Gert Bergman
Journal:  Arthritis Res Ther       Date:  2011-12-12       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.